72 related articles for article (PubMed ID: 10200488)
1. Alteration in p53 pathway and defect in apoptosis contribute independently to cisplatin-resistance.
Ségal-Bendirdjian E; Mannone L; Jacquemin-Sablon A
Cell Death Differ; 1998 May; 5(5):390-400. PubMed ID: 10200488
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin resistance in a murine leukemia cell line is associated with a defective apoptotic process.
Segal-Bendirdjian E; Jacquemin-Sablon A
Exp Cell Res; 1995 May; 218(1):201-12. PubMed ID: 7537690
[TBL] [Abstract][Full Text] [Related]
3. Potential role of transforming growth factor beta1 in drug resistance of tumor cells.
Stoika R; Yakymovych M; Souchelnytskyi S; Yakymovych I
Acta Biochim Pol; 2003; 50(2):497-508. PubMed ID: 12833174
[TBL] [Abstract][Full Text] [Related]
4. Insights into apoptosis mechanisms induced by DNA-damaging agents in Burkitt's lymphoma cells.
Simões Magluta EP; Vasconcelos FC; Maia RC; Klumb CE
Cancer Invest; 2009 Oct; 27(8):830-5. PubMed ID: 19557576
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E
Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
[TBL] [Abstract][Full Text] [Related]
6. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation.
Gibalová L; Sereš M; Rusnák A; Ditte P; Labudová M; Uhrík B; Pastorek J; Sedlák J; Breier A; Sulová Z
Toxicol In Vitro; 2012 Apr; 26(3):435-44. PubMed ID: 22269388
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
Ramondetta L; Mills GB; Burke TW; Wolf JK
Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
[TBL] [Abstract][Full Text] [Related]
9. Brefeldin A is a potent inducer of apoptosis in human cancer cells independently of p53.
Shao RG; Shimizu T; Pommier Y
Exp Cell Res; 1996 Sep; 227(2):190-6. PubMed ID: 8831555
[TBL] [Abstract][Full Text] [Related]
10. Deficient apoptotic process in cisplatin-resistant L1210 cells cannot account for the cellular response to various drug treatments.
Canitrot Y; Frit P; Salles B
Biochem Biophys Res Commun; 1997 May; 234(3):573-7. PubMed ID: 9175754
[TBL] [Abstract][Full Text] [Related]
11. Lactacystin, a proteasome inhibitor, potentiates the apoptotic effect of parthenolide, an inhibitor of NFkappaB activation, on drug-resistant mouse leukemia L1210 cells.
Cory AH; Cory JG
Anticancer Res; 2002; 22(6C):3805-9. PubMed ID: 12552998
[TBL] [Abstract][Full Text] [Related]
12. The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells.
Baptiste N; Friedlander P; Chen X; Prives C
Oncogene; 2002 Jan; 21(1):9-21. PubMed ID: 11791172
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis mediated by p53 in rat neural AF5 cells following treatment with hydrogen peroxide and staurosporine.
McNeill-Blue C; Wetmore BA; Sanchez JF; Freed WJ; Merrick BA
Brain Res; 2006 Sep; 1112(1):1-15. PubMed ID: 16901471
[TBL] [Abstract][Full Text] [Related]
14. Low p21Waf1/Cip1 protein level sensitizes testicular germ cell tumor cells to Fas-mediated apoptosis.
Spierings DC; de Vries EG; Stel AJ; te Rietstap N; Vellenga E; de Jong S
Oncogene; 2004 Jun; 23(28):4862-72. PubMed ID: 15122333
[TBL] [Abstract][Full Text] [Related]
15. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
Kissel CK; Schadendorf D; Röckmann H
Melanoma Res; 2006 Dec; 16(6):527-35. PubMed ID: 17119454
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
[TBL] [Abstract][Full Text] [Related]
17. New alternative phosphorylation sites on the cyclin dependent kinase 1/cyclin a complex in p53-deficient human cells treated with etoposide: possible association with etoposide-induced apoptosis.
Higginbottom K; Jahnke U; Newland AC; Cotter FE; Allen PD
Apoptosis; 2007 Oct; 12(10):1847-55. PubMed ID: 17636382
[TBL] [Abstract][Full Text] [Related]
18. p53 checkpoint-defective cells are sensitive to X rays, but not hypoxia.
Denko NC; Green SL; Edwards D; Giaccia AJ
Exp Cell Res; 2000 Jul; 258(1):82-91. PubMed ID: 10912790
[TBL] [Abstract][Full Text] [Related]
19. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
20. Identification of caspase-independent apoptosis in epithelial and cancer cells.
Cummings BS; Kinsey GR; Bolchoz LJ; Schnellmann RG
J Pharmacol Exp Ther; 2004 Jul; 310(1):126-34. PubMed ID: 15028782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
